Acute renal failure under encorafenib, binimetinib and cetuximab for BRAF V600E-mutated colorectal cancer

Eur J Cancer. 2021 Apr:147:60-62. doi: 10.1016/j.ejca.2021.01.024. Epub 2021 Feb 19.
No abstract available

Keywords: Acute renal failure; Binimetinib; Cetuximab; Encorafenib; Renal insufficiency.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Acute Kidney Injury / diagnosis
  • Acute Kidney Injury / physiopathology
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Benzimidazoles / adverse effects*
  • Carbamates / adverse effects*
  • Cetuximab / adverse effects*
  • Colorectal Neoplasms / drug therapy*
  • Colorectal Neoplasms / genetics
  • Colorectal Neoplasms / pathology
  • Glomerular Filtration Rate / drug effects
  • Humans
  • Kidney / drug effects*
  • Kidney / physiopathology
  • Male
  • Middle Aged
  • Mutation*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Recovery of Function
  • Risk Factors
  • Sulfonamides / adverse effects*
  • Treatment Outcome

Substances

  • Benzimidazoles
  • Carbamates
  • Sulfonamides
  • binimetinib
  • encorafenib
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Cetuximab